{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:00:35Z","timestamp":1768568435014,"version":"3.49.0"},"reference-count":10,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1185\/030079903125002612","type":"journal-article","created":{"date-parts":[[2003,12,10]],"date-time":"2003-12-10T21:19:24Z","timestamp":1071091164000},"page":"13-18","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia"],"prefix":"10.1185","volume":"20","author":[{"given":"P.","family":"Lukacsko","sequence":"first","affiliation":[{"name":"Andrx Laboratories, Inc., Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"Walters","sequence":"additional","affiliation":[{"name":"Andrx Laboratories, Inc., Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. I.","family":"Cullen","sequence":"additional","affiliation":[{"name":"Andrx Laboratories, Inc., Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Niecestro","sequence":"additional","affiliation":[{"name":"Andrx Laboratories, Inc., Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. T.","family":"Friedhoff","sequence":"additional","affiliation":[{"name":"Andrx Laboratories, Inc., Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2008,9,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340090024008"},{"key":"CIT0002","first-page":"1383","volume":"344","author":"The Scandanavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"CIT0003","first-page":"1301","volume":"333","author":"Shepherd J","year":"1995","journal-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"CIT0006","first-page":"43","volume":"151","author":"Bradford RH","year":"1991","journal-title":"I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015899328105"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011111"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85009-3"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.20.1615"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00298-1"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079903125002612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T07:37:00Z","timestamp":1530603420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079903125002612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,9,22]]},"published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1185\/030079903125002612"],"URL":"https:\/\/doi.org\/10.1185\/030079903125002612","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}